ReviewFrontiers in oncology2025

Research advances in immune agonists and their nanoparticles for enhancing the immunotherapeutic efficacy of PD-1 inhibitors in malignancies.

Renjie Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.